雙成藥業(002693.SZ):遭受颱風災害影響 初步估算損失金額約520餘萬元
格隆匯9月9日丨雙成藥業(002693.SZ)公佈,2024年9月6日,海南遭受今年第11號超強颱風“摩羯”襲擊,公司廠區地址位於海南省海口市秀英區興國路16號,受到了颱風與暴雨疊加的災害影響,廠區部分設備設施及系統受損。截至目前,公司在本次颱風災害中損失主要集中在設備及系統工程部分受損,初步估算損失金額約520餘萬元,但未發生人員傷亡。颱風災害過後,公司積極投入復工復產工作中。截至本公吿披露日,公司復工復產工作正在有序推進。目前公司備貨充足,此次災害不會影響公司正常的供貨和銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.